These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38424321)

  • 1. Novel Presentation of Major Histocompatibility Complex Class II Deficiency with Hemophagocytic Lymphohistiocytosis.
    Alroqi FJ; Alhezam MA; Almojali AI; Barhoumi T; Althubaiti N; Alharbi Y; Al Balwi MA; Alrasheed A
    J Clin Immunol; 2024 Mar; 44(3):73. PubMed ID: 38424321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.
    El Hawary RE; Mauracher AA; Meshaal SS; Eldash A; Abd Elaziz DS; Alkady R; Lotfy S; Opitz L; Galal NM; Boutros JA; Pachlopnik Schmid J; Elmarsafy AM
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):856-863. PubMed ID: 30170160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.
    Naamane H; El Maataoui O; Ailal F; Barakat A; Bennani S; Najib J; Hassar M; Saile R; Bousfiha AA
    Eur J Pediatr; 2010 Sep; 169(9):1069-74. PubMed ID: 20414676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in RFXANK gene and low B cell count in a patient with MHC class II deficiency: a case report.
    Abolnezhadian F; Dehghani R; Dehnavi S; Khodadadi A; Shohan M
    Immunol Res; 2020 Aug; 68(4):225-231. PubMed ID: 32578129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
    Mousavi Khorshidi MS; Seeleuthner Y; Chavoshzadeh Z; Behfar M; Hamidieh AA; Alimadadi H; Sherkat R; Momen T; Behniafard N; Eskandarzadeh S; Mansouri M; Behnam M; Mahdavi M; Heydarazad Zadeh M; Shokri M; Alizadeh F; Movahedi M; Momenilandi M; Keramatipour M; Casanova JL; Cobat A; Abel L; Shahrooei M; Parvaneh N
    J Clin Immunol; 2023 Nov; 43(8):1941-1952. PubMed ID: 37584719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome.
    Klein C; Lisowska-Grospierre B; LeDeist F; Fischer A; Griscelli C
    J Pediatr; 1993 Dec; 123(6):921-8. PubMed ID: 8229525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.
    Ouederni M; Vincent QB; Frange P; Touzot F; Scerra S; Bejaoui M; Bousfiha A; Levy Y; Lisowska-Grospierre B; Canioni D; Bruneau J; Debré M; Blanche S; Abel L; Casanova JL; Fischer A; Picard C
    Blood; 2011 Nov; 118(19):5108-18. PubMed ID: 21908431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and Nodular Hyperinflammation in a Patient with Refractory Familial Hemophagocytic Lymphohistiocytosis 2.
    Segal JE; Daley JD; Barnum JL; Salgado CM; Reyes-Mugica M; Schneider C; Gumus S; Thakrar D; Allen SW; Canna SW
    J Clin Immunol; 2021 Jul; 41(5):987-991. PubMed ID: 33570715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients.
    Ben-Mustapha I; Ben-Farhat K; Guirat-Dhouib N; Dhemaied E; Larguèche B; Ben-Ali M; Chemli J; Bouguila J; Ben-Mansour L; Mellouli F; Khemiri M; Béjaoui M; Barbouche MR
    J Clin Immunol; 2013 May; 33(4):865-70. PubMed ID: 23314770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Hemophagocytic Lymphohistiocytosis secondary to UNC13D mutation: a report of two cases.
    Sadeghi P; Esslami GG; Rokni-Zadeh H; Changi-Ashtiani M; Mohsenipour R
    BMC Pediatr; 2022 Nov; 22(1):667. PubMed ID: 36401200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophagocytic lymphohistiocytosis is associated with Bartonella henselae infection in a patient with multiple susceptibility genes.
    Yang T; Mei Q; Zhang L; Chen Z; Zhu C; Fang X; Geng S; Pan A
    Ann Clin Microbiol Antimicrob; 2020 Jun; 19(1):28. PubMed ID: 32517705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency.
    Drago E; Garbarino F; Signa S; Grossi A; Schena F; Penco F; Santori E; Candotti F; Boztug K; Volpi S; Gattorno M; Caorsi R
    Front Immunol; 2022; 13():937108. PubMed ID: 36159847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemophagocytic lymphohistiocytosis caused by hematogenous disseminated pulmonary tuberculosis: A case report].
    Li QY; Liang Y; Dai NN; Wang YX; Zhu BT; Wu R; Zhu H; Sun YC
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1219-1223. PubMed ID: 36533359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of Hemophagocytic Lymphohistiocytosis in Infants With Severe Combined Immunodeficiency: Our Experience From Chandigarh, North India.
    Vignesh P; Anjani G; Kumrah R; Singh A; Mondal S; Nameirakpam J; Jindal A; Suri D; Sharma M; Kaur G; Sharma S; Gupta K; Sreedharanunni S; Rawat A; Singh S
    Front Immunol; 2022; 13():867753. PubMed ID: 35812426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated Tuberculosis Associated Hemophagocytic Lymphohistiocytosis in a Pregnant Woman With Evans syndrome: A Case Report and Literature Review.
    Shi YF; Shi XH; Zhang Y; Chen JX; Lai WX; Luo JM; Ba JH; Wang YH; Chen JN; Wu BQ
    Front Immunol; 2021; 12():676132. PubMed ID: 34177917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Secondary Hemophagocytic Lymphohistiocytosis With Disseminated Infection in Chronic Granulomatous Disease-A Serious Cause of Mortality.
    Squire JD; Vazquez SN; Chan A; Smith ME; Chellapandian D; Vose L; Teppa B; Hanson IC; Chinn IK; Forbes-Satter L; Seeborg FO; Nicholas SK; Martinez CA; Allen CE; Connors TJ; Satwani P; Shtessel M; Ale H; Noroski LM; Rider NL; Milner JD; Leiding JW
    Front Immunol; 2020; 11():581475. PubMed ID: 33362767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC Class II Deficiency with Normal CD4+ T Cell Counts: A Case Report.
    Abolnezhadian F; Saeedi-Boroujeni A; Iranparast S
    Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):594-600. PubMed ID: 30644704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review.
    Wei A; Ma H; Zhang L; Li Z; Zhang Q; Wang D; Zhang L; Lian H; Zhang R; Wang T
    BMC Pediatr; 2020 Mar; 20(1):100. PubMed ID: 32126983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophagocytic Lymphohistiocytosis in Renal Transplant Recipients: A 2-Case Report.
    Mascia G; Argiolas D; Carta E; Ibba S; Piredda GB
    Transplant Proc; 2020 Jun; 52(5):1566-1569. PubMed ID: 32389490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.